Pharma app development: where an app helps and where rules apply

Four kinds of pharma app

Field force apps help sales and medical representatives plan visits, record interactions and present approved material. Healthcare professional apps deliver product information, dosing tools or congress agendas. Patient apps support adherence, symptom tracking and access to support programs. Clinical trial apps collect data from participants.

Each has a different audience and regulator. Promotional material for professionals is tightly controlled. Patient-facing material has to avoid anything that reads as unapproved advice. Trial apps sit inside protocols approved by ethics committees.

We build software, not claims. Content comes from your approved sources, goes through your review process and is loaded into the app. We design the app so content can be updated without a new release, and every version is logged.

Scale and geography change the plan. A global company needs the same app approved country by country, with local languages, local prescribing information and different promotional codes. A smaller company may start in one market. We structure content so each country has its own approved set.

Matching the app to the rule set

Adverse events are a special case. If an app collects free text from patients or professionals, a user may report a side effect, and your company may have a legal duty to capture and report it. Decide with your pharmacovigilance team how the app routes such reports before you design the text boxes.

Versioning gets attention in every audit. Each piece of content should carry an approval code, an expiry date and a way to be withdrawn quickly from every device. We build withdrawal as a remote switch, so out-of-date material can disappear at once.

Integrations and records

Field apps usually connect to a CRM such as Veeva or Salesforce Life Sciences. Those platforms have their own mobile offerings, and a custom app is justified only where they fall short. Where it is, we use their APIs under your license and your IT team's access rules.

Regulated records need an audit trail: who changed what, when. Where electronic records fall under rules such as FDA 21 CFR Part 11 or EU Annex 11, validation work is needed, and your quality team owns it. We provide documentation to support validation and keep change logs, but we do not validate the system for you.

Many companies distribute apps privately rather than publicly, through mobile device management or Apple's custom app distribution. That limits exposure of professional-only content.

Privacy and store policy

Patient apps handle health data. In the US, HIPAA may not apply to a manufacturer directly, but state health privacy laws and FTC rules can. In the EU and UK, GDPR treats health data as special category data, and clinical trial data has its own rules. Check with your data protection officer.

Apple and Google both scrutinize apps that promote prescription drugs. Apple's guidelines restrict apps that encourage consumption of controlled substances and require that medical apps be accurate. Expect extra questions in review and prepare notes.

Healthcare professionals expect speed and clarity, and reps work in clinics with poor signal. Offline access to approved material is a common must-have.

Price and approach

Projects start at $1,500 and our rate is $30 an hour. A simple internal tool, such as a congress agenda or an approved-content viewer, is a small project. Anything with CRM links, audit trails, trial data or multi-country approvals is larger, and the review calendar drives the schedule more than coding does. Fixed quote within one working day of a short call, for a defined phase.

We work remotely from Pune, sign confidentiality agreements and use dummy content in development. See mobile app development, healthcare app development and our pharmacy app page for related work.

A discovery workshop is a practical first step. In a short session with your medical, legal and IT contacts, we map the approval path, the systems involved and the data flows. The output is a plain scope document that every reviewer can sign.